Expression of ErbB2 and ErbB3 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Salcedo, M. T. [1 ]
Montero, M. A. [1 ]
Hernandez-Losa, J. [1 ]
Teixido, C. [1 ]
Allende, H. [1 ]
Felip, E. [1 ]
Murtra-Garrell, N. [1 ]
Pallisa, E. [1 ]
Canela, M. [1 ]
Ramon y Cajal, S. [1 ]
Tallada, N. [1 ]
机构：
[1] Univ Hosp Vall Hebron, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
2039
引用
收藏
页码：489A / 489A
页数：1
相关论文
共 50 条
  • [41] Clinicopathologic and molecular characteristics in ERBB2 (HER2)-altered non-small cell lung cancer
    Lee, Y.
    Lee, B.
    Choi, Y.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S151 - S152
  • [42] Dual targeting of ErbB2/ErbB3 for treatment of SCL3A2-NRG1-mediated lung cancer
    Jo, Jeong Yeon
    Shin, Dong Hoon
    Han, Ji-Youn
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer
    Shin, Dong Hoon
    Jo, Jeong Yeon
    Han, Ji-Youn
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 2024 - 2033
  • [44] Prognostic value of ERBB2 amplification and protein expression in small cell lung cancer
    Cebollero Presmanes, Maria
    Sanchez-Mora, Nora
    Garcia-Gomez, Ramon
    Luisa Herranz Aladro, Maria
    Alvarez-Fernandez, Emilio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (03): : 122 - 126
  • [45] Evaluation of AZD8931, an Equipotent Inhibitor of erbB1, erbB2, and erbB3 Receptor Signaling, on Ligand Stimulated Breast Cancer Cell Lines with Differing Levels of erbB2 Expression
    Marshall, G.
    Klinowska, T. C. M.
    Mills, E. A.
    Ogilvie, D.
    Hickinson, D. M.
    Speake, G.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 785S
  • [46] Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    José Baselga
    Sandra M. Swain
    Nature Reviews Cancer, 2009, 9 : 463 - 475
  • [47] Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3
    Sak, Malgorzata Magdalena
    Szymanska, Monika
    Bertelsen, Vibeke
    Hasmann, Max
    Madshus, Inger Helene
    Stang, Espen
    CARCINOGENESIS, 2013, 34 (09) : 2031 - 2038
  • [48] C-erbB-2 oncoprotein expression in operable non-small cell lung cancer
    Giatromanolaki, A
    Gorgoulis, V
    Chetty, R
    Koukourakis, MI
    Whitehouse, R
    Kittas, C
    Veslemes, M
    Gatter, KC
    Iordanoglou, I
    ANTICANCER RESEARCH, 1996, 16 (02) : 987 - 993
  • [49] Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    Baselga, Jose
    Swain, Sandra M.
    NATURE REVIEWS CANCER, 2009, 9 (07) : 463 - 475
  • [50] ERBB3 enhances ERBB2 activation leading to increased cell motility and invasion in bladder cancer cells
    Kotwal, Sanjeev
    Tomlinson, Darren
    Pitt, Eva
    Paul, Alan
    Knowles, Margaret
    CANCER RESEARCH, 2009, 69
12345